Fedor Moiseenko
City Hospital No. 40(RU)Institute of Oncology NN Petrov(RU)City Clinical Oncology Center(RU)Ministry of Health(MN)National Library of Russia(RU)State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care(RU)North-Western State Medical University named after I.I. Mechnikov(RU)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer(2022)423 cited
- → Tumor acidity: From hallmark of cancer to target of treatment(2022)146 cited
- → Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous EGFR -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial(2024)105 cited
- → Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met–overexpressing (OE) advanced non-small cell lung cancer (NSCLC).(2022)70 cited
- → Effect of silver oxide nanoparticles on tumor growth in vivo(2008)67 cited
- → Trifluridine–tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study